Astrazeneca (AZN) ended the recent trading session at $174.93, demonstrating a -1.66% change from the preceding day’s closing price. This change lagged the S&P 500’s 1.09% gain on the day. On the other hand, the Dow registered a gain of 0.14%, and the technology-centric Nasdaq increased by 1.91%.

The pharmaceutical’s stock has dropped by 5.11% in the past month, falling short of the Medical sector’s gain of 3.16% and the S&P 500’s gain of 0.29%.

Analysts and investors alike will be keeping a close eye on the performance of Astrazeneca in its upcoming earnings disclosure. The company is forecasted to report an EPS of $2.1, showcasing a 3.67% downward movement from the corresponding quarter of the prior year. Meanwhile, the…